PDC and breast carcinoma: We used a linear 18-4 peptide that was engineered to bind breast cancer cells via the cell-surface K1 receptor [23,28] The cellular uptake of peptide 18-4 and its PDC takes place via receptor-mediated endocytosis in breast cancer cells [25,48].